Maltês Extra-virgin Olive Oil | Penang Web and Graphic Design Agency – GurlstudioPenang Web and Graphic Design Agency gurlstudio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurlstudio.com Daily Mail and Mail on Sunday newspapers.
Brasilia, 19 ago (Prensa Latina) El empresario brasileño Francisco Maximiano, propietario de la empresa Precisa Medicamentos, expondrá hoy en la comisión senatorial que supervisa la gestión gubernamental ante la pandemia (CPI) sobre el contrato para adquirir Covaxin, vacuna india antiCovid-19.
Citing Lack of Authorisation and No Delivery of Doses, Brazil Cancels Covaxin Contract thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewire.in Daily Mail and Mail on Sunday newspapers.
Indian drug-maker pulls out from Brazilian vaccine deal amid charges of graft
Issued on:
25/07/2021 - 10:17 Brazilian President Jair Bolsonaro is accused of knowing about but failing to report alleged corruption in the purchase of a coronavirus vaccine EVARISTO SA AFP 4 min An Indian drug-maker withdrew from a contract to sell vaccines to Brazil amid charges of graft that rocked the presidency of Jair Bolsonaro. Bharat Biotech has denied wrongdoing in the deal to sell 20 million shots to the Covid-hit country. Advertising Read more
The company did not give any reason for walking out of the November deal worth 275 million Euros with two firms which included its Brazilian representative Precisa Medicamentos.
Bharat Biotech’s Covaxin vaccine is running into deeper troubles abroad
Bharat Biotech’s Covaxin vaccine is running into deeper troubles abroad
The Brazilian government’s inquiry into the firm, which has developed India’s homegrown Covid-19 dose, has intensified over the past two weeks.
Bharat Biotech may be in a hotter soup in Brazil.
The Brazilian government’s inquiry into Bharat Biotech, which has developed and manufactures India’s homegrown Covid-19 vaccine Covaxin, has intensified over the past two weeks. The Brazilian parliamentary commission looking into the company’s deal to sell vaccines in the Latin American country will now also investigate an alleged payment of $200,000 from Bharat Biotech to the India-Brazil Chamber of Commerce,